Overview
- ANMAT has warned that tablets labeled as Ozempic and allegedly made by Pharma Argentina SA are counterfeit.
- The regulator noted that Ozempic is only marketed in injectable form and no oral semaglutide tablets are authorized.
- Pharma Argentina SA is not registered with ANMAT to import or produce any medications.
- Officials have opened a criminal investigation after learning the fake tablets were offered online.
- ANMAT highlighted Dutide as the sole approved domestic semaglutide tablet alternative.